2 completed, 1 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Axio Research. LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program Tetanus and Diphtheria (Td) Vaccine - Healthy | Phase 1 | Completed | Biomat USA, Inc. | 300 | 2016-08-22 | 2021-07-20 |
| Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome Placebo, EPI-743 15 mg/kg, EPI-743 5 mg/kg - Leigh Syndrome | Phase 2 | Completed | PTC Therapeutics | 35 | 2012-10-31 | 2020-08-31 |
| Niacin Plus Statin to Prevent Vascular Events Extended release niacin, Simvastatin - Cardiovascular Diseases, Heart Diseases | Phase 3 | Terminated | Axio Research. LLC | 3414 | 2005-09-01 | 2016-04-06 |
Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Heart Diseases (1) · Leigh Disease (1) · Mitochondrial Diseases (1) · Myocardial Infarction (1) · Stroke (1) · Tetanus (1)
Niacin (1) · Simvastatin (1) · Tetanus Toxoid (1) · Vaccines (1) · alpha-tocotrienol quinone (1)
United States (3) · Canada (1)
Jeffrey Probstfield, MD (1) · Marilyn Rosa-Bray, MD (1) · Ruth McBride (1) · William E. Boden, MD (1)
PMID 22085343, PMID 23881958, PMID 23916935, PMID 23973688, PMID 26708287, PMID 29627296, PMID 30371334, PMID 34134520
U01HL081616 (1), U01HL081649 (1)